SBRA
Sabra Health Care REIT, Inc.
REIT - Healthcare Facilities
Market Cap$5.17B
5Y Perf.+52.3%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SBRA vs OHI
Revenue, margins, valuation, and 5-year total return — side by side.
OHI
Omega Healthcare Investors, Inc.
REIT - Healthcare Facilities
Market Cap$13.72B
5Y Perf.+47.9%
SBRA vs OHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SBRA | OHI |
|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $5.17B | $13.72B |
| Revenue (TTM) | $813M | $1.24B |
| Net Income (TTM) | $156M | $632M |
| Gross Margin | 63.5% | 85.5% |
| Operating Margin | 29.0% | 64.3% |
| Forward P/E | 29.7x | 23.4x |
| Total Debt | $2.55B | $4.26B |
| Cash & Equiv. | $72M | $27M |
SBRA vs OHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SBRA
OHI
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 100 | 152.3 | +52.3% |
| Omega Healthcare In… (OHI) | 100 | 147.9 | +47.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SBRA vs OHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: OHI leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Sabra Health Care REIT, Inc. is the stronger pick specifically for dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
SBRA
Sabra Health Care REIT, Inc.
The Real Estate Income Play
SBRA is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta -0.06, yield 5.8%
- Beta -0.06, yield 5.8%, current ratio 0.56x
- 5.8% yield, vs OHI's 5.5%
Best for: income & stability and defensive
OHI
Omega Healthcare Investors, Inc.
The Real Estate Income Play
OHI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 14.0%, EPS growth 25.2%, 3Y rev CAGR 10.9%
- 115.0% 10Y total return vs SBRA's 54.1%
- Lower volatility, beta -0.13, Low D/E 78.2%, current ratio 3.46x
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | OHI | 14.0% FFO/revenue growth vs SBRA's 10.2% |
| Value | OHI | Lower P/E (23.4x vs 29.7x) |
| Quality / Margins | OHI | 51.0% margin vs SBRA's 19.2% |
| Stability / Safety | OHI | Lower D/E ratio (78.2% vs 90.3%) |
| Dividends | SBRA | 5.8% yield, vs OHI's 5.5% |
| Momentum (1Y) | OHI | +35.8% vs SBRA's +21.3% |
| Efficiency (ROA) | OHI | 6.1% ROA vs SBRA's 2.8%, ROIC 6.0% vs 3.8% |
SBRA vs OHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2011
SBRA vs OHI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLOHILAGGINGSBRA
SBRASabra Health Care REI…
1leads
OHIOmega Healthcare Inve…
2leads
6 Total Categories
CATEGORYLEADERvs SBRAMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
OHI5/6
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
OHI7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
SBRA1/1
Income & Cash Flow (Last 12 Months)
OHI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OHI is the larger business by revenue, generating $1.2B annually — 1.5x SBRA's $813M. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to SBRA's 19.2%. On growth, SBRA holds the edge at +20.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SBRASabra Health Care… | OHIOmega Healthcare … |
|---|---|---|
| RevenueTrailing 12 months | $813M | $1.2B |
| EBITDAEarnings before interest/tax | $432M | $1.1B |
| Net IncomeAfter-tax profit | $156M | $632M |
| Free Cash FlowCash after capex | $367M | $912M |
| Gross MarginGross profit ÷ Revenue | +63.5% | +85.5% |
| Operating MarginEBIT ÷ Revenue | +29.0% | +64.3% |
| Net MarginNet income ÷ Revenue | +19.2% | +51.0% |
| FCF MarginFCF ÷ Revenue | +45.1% | +73.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.8% | +16.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.9% | +42.4% |
OHI leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
Evenly matched — SBRA and OHI each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 23.7x trailing earnings, OHI trades at a 26% valuation discount to SBRA's 32.0x P/E. On an enterprise value basis, OHI's 16.7x EV/EBITDA is more attractive than SBRA's 17.0x.
| Metric | SBRASabra Health Care… | OHIOmega Healthcare … |
|---|---|---|
| Market CapShares × price | $5.2B | $13.7B |
| Enterprise ValueMkt cap + debt − cash | $7.6B | $17.9B |
| Trailing P/EPrice ÷ TTM EPS | 32.03x | 23.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.71x | 23.37x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.02x |
| EV / EBITDAEnterprise value multiple | 16.96x | 16.70x |
| Price / SalesMarket cap ÷ Revenue | 6.67x | 11.45x |
| Price / BookPrice ÷ Book value/share | 1.77x | 2.63x |
| Price / FCFMarket cap ÷ FCF | 14.83x | 15.62x |
Evenly matched — SBRA and OHI each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
OHI leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $6 for SBRA. OHI carries lower financial leverage with a 0.78x debt-to-equity ratio, signaling a more conservative balance sheet compared to SBRA's 0.90x. On the Piotroski fundamental quality scale (0–9), OHI scores 6/9 vs SBRA's 5/9, reflecting solid financial health.
| Metric | SBRASabra Health Care… | OHIOmega Healthcare … |
|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +11.9% |
| ROA (TTM)Return on assets | +2.8% | +6.1% |
| ROICReturn on invested capital | +3.8% | +6.0% |
| ROCEReturn on capital employed | +5.2% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.90x | 0.78x |
| Net DebtTotal debt minus cash | $2.5B | $4.2B |
| Cash & Equiv.Liquid assets | $72M | $27M |
| Total DebtShort + long-term debt | $2.6B | $4.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.40x | 3.83x |
OHI leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — SBRA and OHI each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OHI five years ago would be worth $16,374 today (with dividends reinvested), compared to $15,239 for SBRA. Over the past 12 months, OHI leads with a +35.8% total return vs SBRA's +21.3%. The 3-year compound annual growth rate (CAGR) favors SBRA at 28.5% vs OHI's 23.0% — a key indicator of consistent wealth creation.
| Metric | SBRASabra Health Care… | OHIOmega Healthcare … |
|---|---|---|
| YTD ReturnYear-to-date | +8.6% | +6.5% |
| 1-Year ReturnPast 12 months | +21.3% | +35.8% |
| 3-Year ReturnCumulative with dividends | +112.3% | +86.0% |
| 5-Year ReturnCumulative with dividends | +52.4% | +63.7% |
| 10-Year ReturnCumulative with dividends | +54.1% | +115.0% |
| CAGR (3Y)Annualised 3-year return | +28.5% | +23.0% |
Evenly matched — SBRA and OHI each lead in 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — SBRA and OHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than SBRA's -0.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 97.3% from its 52-week high vs OHI's 93.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SBRASabra Health Care… | OHIOmega Healthcare … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.06x | -0.13x |
| 52-Week HighHighest price in past year | $21.07 | $49.14 |
| 52-Week LowLowest price in past year | $17.08 | $35.09 |
| % of 52W HighCurrent price vs 52-week peak | +97.3% | +93.8% |
| RSI (14)Momentum oscillator 0–100 | 52.5 | 49.1 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 1.9M |
Evenly matched — SBRA and OHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
SBRA leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates SBRA as "Hold" and OHI as "Hold". Consensus price targets imply 6.7% upside for OHI (target: $49) vs 3.4% for SBRA (target: $21). For income investors, SBRA offers the higher dividend yield at 5.78% vs OHI's 5.45%.
| Metric | SBRASabra Health Care… | OHIOmega Healthcare … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $21.20 | $49.14 |
| # AnalystsCovering analysts | 29 | 28 |
| Dividend YieldAnnual dividend ÷ price | +5.8% | +5.5% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $1.18 | $2.51 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
SBRA leads this category, winning 1 of 1 comparable metric.
Key Takeaway
OHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SBRA leads in 1 (Analyst Outlook). 3 tied.
Best OverallOmega Healthcare Investors,… (OHI)Leads 2 of 6 categories
Loading custom metrics...
SBRA vs OHI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SBRA or OHI a better buy right now?
For growth investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger pick with 14. 0% revenue growth year-over-year, versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 23. 7x trailing P/E (23. 4x forward), making it the more compelling value choice. Analysts rate Sabra Health Care REIT, Inc. (SBRA) a "Hold" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBRA or OHI?
On trailing P/E, Omega Healthcare Investors, Inc.
(OHI) is the cheapest at 23. 7x versus Sabra Health Care REIT, Inc. at 32. 0x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 23. 4x.
03Which is the better long-term investment — SBRA or OHI?
Over the past 5 years, Omega Healthcare Investors, Inc.
(OHI) delivered a total return of +63. 7%, compared to +52. 4% for Sabra Health Care REIT, Inc. (SBRA). Over 10 years, the gap is even starker: OHI returned +115. 0% versus SBRA's +54. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBRA or OHI?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus Sabra Health Care REIT, Inc. 's -0. 06β — meaning SBRA is approximately -49% more volatile than OHI relative to the S&P 500. On balance sheet safety, Omega Healthcare Investors, Inc. (OHI) carries a lower debt/equity ratio of 78% versus 90% for Sabra Health Care REIT, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SBRA or OHI?
By revenue growth (latest reported year), Omega Healthcare Investors, Inc.
(OHI) is pulling ahead at 14. 0% versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). On earnings-per-share growth, the picture is similar: Omega Healthcare Investors, Inc. grew EPS 25. 2% year-over-year, compared to 18. 5% for Sabra Health Care REIT, Inc.. Over a 3-year CAGR, OHI leads at 10. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SBRA or OHI?
Omega Healthcare Investors, Inc.
(OHI) is the more profitable company, earning 49. 3% net margin versus 20. 1% for Sabra Health Care REIT, Inc. — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus 34. 1% for SBRA. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SBRA or OHI more undervalued right now?
On forward earnings alone, Omega Healthcare Investors, Inc.
(OHI) trades at 23. 4x forward P/E versus 29. 7x for Sabra Health Care REIT, Inc. — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OHI: 6. 7% to $49. 14.
08Which pays a better dividend — SBRA or OHI?
All stocks in this comparison pay dividends.
Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5. 8%, versus 5. 5% for Omega Healthcare Investors, Inc. (OHI).
09Is SBRA or OHI better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 5% yield, +115. 0% 10Y return). Both have compounded well over 10 years (OHI: +115. 0%, SBRA: +54. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SBRA and OHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(SBRA: 20.8% · OHI: 16.7%)Net Margin>
%
(SBRA: 19.2% · OHI: 51.0%)P/E Ratio<
x
(SBRA: 32.0x · OHI: 23.7x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.